Medical Patent Law Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Patent Law Weekly


We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Pressure BioSciences

Reports describe the most recent news from Pressure BioSciences

This trend article is an immediate alert from NewsRx to identify the most recent news developments at Pressure BioSciences.

Report 1: Pressure BioSciences, Inc. (PBIO) sold a pressure cycling technology (PCT) sample preparation system (PCT SPS) to the U.S. Centers for Disease Control and Prevention (CDC).

Scientists at the CDC are expected to use the PCT SPS for a variety of research applications, including the extraction of proteins from influenza virus; from bacterial agents such as Clostridium botulinum and Cryptosporidium parasites; and from tissues...

• View Other Issues of Medical Patent Law Weekly
  
• View Other NewsRx Publications